Literature DB >> 21106424

Effects of interventions on intra- and interobserver agreement on interpretation of nonalcoholic fatty liver disease histology.

Samer Gawrieh1, Darly M Knoedler, Kia Saeian, James R Wallace, Richard A Komorowski.   

Abstract

Accurate and reproducible interpretation of nonalcoholic fatty liver disease (NAFLD) histology has significant clinical and research-related implications. We evaluated the impact of 2 interventions ([1] review of illustrative histologic images of NAFLD with the study pathologists; [2] use of a scoring sheet with written diagnostic criteria for different NAFLD phenotypes) on intra- and interobserver agreement on interpretation of NAFLD histology. Before and after the interventions, 2 pathologists twice read 65 liver biopsies done for evaluation of suspected NAFLD. The intra- and interobserver agreement was highest on assessment of steatosis and fibrosis. The interventions significantly improved the intraobserver agreement only on assessment of hepatocellular ballooning. The interobserver agreement was only fair on assessment of lobular inflammation, ballooning, and diagnostic classification and did not improve after the interventions. Methods to improve interobserver agreement on assessment of lobular inflammation and ballooning are needed and would likely increase pathologists' agreement on NAFLD diagnostic classification. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21106424     DOI: 10.1016/j.anndiagpath.2010.08.001

Source DB:  PubMed          Journal:  Ann Diagn Pathol        ISSN: 1092-9134            Impact factor:   2.090


  25 in total

1.  Sonographic assessment of fatty liver: intraobserver and interobserver variability.

Authors:  Mustafa Cengiz; Senem Sentürk; Bulent Cetin; Aylin Hasanefendioğlu Bayrak; Senem Uysal Bilek
Journal:  Int J Clin Exp Med       Date:  2014-12-15

2.  Reversing Advanced Hepatic Fibrosis in NASH: Clearly Possible, but Widely at Hand?

Authors:  Stephen H Caldwell; Curtis K Argo
Journal:  Dig Dis Sci       Date:  2015-01-25       Impact factor: 3.199

3.  Automated quantification of fibrosis-related parameters using dual-photon microscopy replace diagnosis of pathologists in NAFLD.

Authors:  Yoshio Sumida; Takeshi Okanoue; Atsushi Nakajima
Journal:  Hepatobiliary Surg Nutr       Date:  2020-12       Impact factor: 7.293

4.  Automatic quantification of lobular inflammation and hepatocyte ballooning in nonalcoholic fatty liver disease liver biopsies.

Authors:  Scott Vanderbeck; Joseph Bockhorst; David Kleiner; Richard Komorowski; Naga Chalasani; Samer Gawrieh
Journal:  Hum Pathol       Date:  2015-02-19       Impact factor: 3.466

5.  Association between Wisteria floribunda agglutinin-positive Mac-2 binding protein and the fibrosis stage of non-alcoholic fatty liver disease.

Authors:  Masanori Abe; Teruki Miyake; Atsushi Kuno; Yasuharu Imai; Yoshiyuki Sawai; Keisuke Hino; Yuichi Hara; Shuhei Hige; Michiie Sakamoto; Gotaro Yamada; Masayoshi Kage; Masaaki Korenaga; Yoichi Hiasa; Masashi Mizokami; Hisashi Narimatsu
Journal:  J Gastroenterol       Date:  2014-10-18       Impact factor: 7.527

Review 6.  Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.

Authors:  Yoshio Sumida; Atsushi Nakajima; Yoshito Itoh
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

7.  Standardising the interpretation of liver biopsies in non-alcoholic fatty liver disease clinical trials.

Authors:  Rish K Pai; David E Kleiner; John Hart; Oyedele A Adeyi; Andrew D Clouston; Cynthia A Behling; Dhanpat Jain; Sanjay Kakar; Mayur Brahmania; Lawrence Burgart; Kenneth P Batts; Mark A Valasek; Michael S Torbenson; Maha Guindi; Hanlin L Wang; Veeral Ajmera; Leon A Adams; Claire E Parker; Brian G Feagan; Rohit Loomba; Vipul Jairath
Journal:  Aliment Pharmacol Ther       Date:  2019-10-03       Impact factor: 8.171

8.  Effects of n-3 fish oil on metabolic and histological parameters in NASH: a double-blind, randomized, placebo-controlled trial.

Authors:  Curtis K Argo; James T Patrie; Carolin Lackner; Thomas D Henry; Eduard E de Lange; Arthur L Weltman; Neeral L Shah; Abdullah M Al-Osaimi; Patcharin Pramoonjago; Saumya Jayakumar; Lukas P Binder; Winsor D Simmons-Egolf; Sandra G Burks; Yongde Bao; Ann Gill Taylor; Jessica Rodriguez; Stephen H Caldwell
Journal:  J Hepatol       Date:  2014-09-06       Impact factor: 25.083

9.  Controversies in the Diagnosis and Management of NAFLD and NASH.

Authors:  Mary E Rinella; Rohit Loomba; Stephen H Caldwell; Kris Kowdley; Michael Charlton; Brent Tetri; Stephen A Harrison
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-04

10.  Accuracy of liver stiffness measurement and controlled attenuation parameter using FibroScan® M/XL probes to diagnose liver fibrosis and steatosis in patients with nonalcoholic fatty liver disease: a multicenter prospective study.

Authors:  Satoshi Oeda; Hirokazu Takahashi; Kento Imajo; Yuya Seko; Yuji Ogawa; Michihisa Moriguchi; Masato Yoneda; Keizo Anzai; Shinichi Aishima; Masayoshi Kage; Yoshito Itoh; Atsushi Nakajima; Yuichiro Eguchi
Journal:  J Gastroenterol       Date:  2019-10-25       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.